Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1431-1436

  Gifford, Andrew N ^a   Ashby Jr , Charles R ^a,b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ACETYLCHOLINE; CANNABINOID; CANNABINOID RECEPTOR; RIMONABANT;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; HIPPOCAMPUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HIPPOCAMPUS; MALE; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0030441132     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. ADAMS, I. B., RYAN, W., SINGER, M., THOMAS, B. F., COMPTON, D. R., RAZDAN, R. K. AND MARTIN, B. R.: Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J. Pharmacol. Exp. Ther. 273: 1172-1181, 1995.
2. 2-adrenoceptor. Nature (Lond.) 374:272-276, 1995.
3. BUTCHER, L. L. AND WOOLF, N. J.: Histochemical distribution of acetylcholinesterase in the central nervous system: Clues to the localization of cholinergic neurons. In Handbook of Chemical Neuroanatomy, Vol. 3: Classical Transmitters and Transmitter Receptors in the CNS 3, Part II, ed. by A. Björklund, T. Hökfelt and M. J. Kuhar, pp. 1-50, Elsevier, New York, 1984.
4. 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 263: 1118-1126, 1992.
5. COSTA, T., OGINO, Y., MUNSON, P. J., ONARAN, O. AND RODBARD, D.: Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: Thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol. 41: 549-560, 1992.
6. D'AMBRA, T. E., ESTEP, K. G., BELL, M. R., EISSENSTAT, M. A., JOSEF, K. A., WARD, S. J., HAYCOCK, D. A., BAIZMAN, E. R., CASIANO, F. M., BEGUN, N. C., CHIPPARI, S. M., GREGO, J. D., KULLNIG, R. K. AND DALEY, G. T.: Conformationally restrained analogues of pravadoline: Nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. J. Med. Chem. 35: 124-135, 1992.
7. DEADWYLER, S. A., HAMPSON, R. E., Mu, J., WHYTE, A. AND CHILDERS, S.: Cannabinoids modulate voltage-sensitive potassium A current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther. 273: 734-743, 1995.
8. DEVANE, W. A., DYSARZ, F. A. III, JOHNSON, M. R., MELVIN, L. S. AND HOWLETT, A. C.: Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34: 605-613, 1988.
9. DEVANE, W. A., HANUS, L., BREUER, A., PERTWEE, R. G., STEVENSON, L. A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. AND MECHOULAM, R.: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash. DC) 258: 1946-1949, 1992.
10. DI MARZO, V., FONTANA, A., CADAS, H., SCHINELLI, S., CIMINO, G., SCHWARTZ, J.-C. AND PIOMELLI, D.: Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature (Lond.) 372: 686-691, 1994.
11. DREW, W. L. AND MILLER, L. L.: Cannabis: Neural mechanisms and behavior - A theoretical review. Pharmacology 11: 12-32, 1974.
12. 2+-dependent release from rat brain of cannabinoid receptor binding activity. J. Neurochem. 58: 780-782, 1992.
13. EVANS, D. M. LAKE, J. T., JOHNSON, M. R. AND HOWLETT, A. C.: Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization. J. Pharmacol. Exp. Ther. 268: 1271-1277, 1994.
14. FISHER, K. A., CHEN, K. S., GAGE, F. H. AND BJÖRKLUND, A.: Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging. Neurobiol. Aging 13: 9-23, 1991.
15. FRASER, K. A., POUCET, B., PARTLOW, G. AND HERRMANN, T.: Role of medial and lateral septum in a variable goal spatial problem solving task. Physiol. Behav. 50: 739-744, 1991.
16. HANUS, L., GOPHER, A., ALMOG, S. AND MECHOULAM, R.: Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. J. Med. Chem. 36: 3032-3034, 1993.
17. HENRY, D. J. AND CHAVKIN, C.: Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci. Lett. 186: 91-94, 1995.
18. HERKENHAM, M., LYNN, A. B., DE COSTA, B. R. AND RICHFIELD, E. K.: Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547: 267-274, 1991a.
19. HERKENHAM, M., LYNN, A. B., JOHNSON, M. R., MELVIN, L. S., DE COSTA, B. R. AND RICE, K. C.: Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J. Neurosci. 11: 563-583, 1991b.
20. HERKENHAM, M., LYNN, A. B., LITTLE, M. D., JOHNSON, M. R., MELVIN, L. S., DECOSTA, B. R. AND RICE, K. C.: Cannabinoid receptor localization in the brain. Proc. Natl. Acad. Sci. U.S.A. 87: 1932-1936, 1990.
21. HOLLISTER, L. E.: Health aspects of cannabis. Pharmacol. Rev. 38: 1-20, 1986.
22. HOWLETT, A. C. AND FLEMING, R. M.: Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol. Pharmacol. 26: 532-538, 1984.
23. HOWLETT, A. C., JOHNSON, M. R., MELVIN, L. S. AND MILNE, G. M.: Nonclassical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model. Mol. Pharmacol. 33: 297-302, 1988.
24. JANSEN, E. M., HAYCOCK, D. A., WARD, S. J. AND SEYBOLD, V. S.: Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res. 575: 93-102, 1992.
25. LYNCH, G. S., ROSE, G. AND GALL, C. M.: Anatomical and functional aspects of the septo-hippocampal projections. In Ciba Foundation Symposium 58: Functions of the Septo-Hippocampal System, pp. 5-24, Elsevier, New York, 1978.
26. MACKIE, K. AND HILLE, N.: Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. U.S.A. 89: 3825-3829, 1992.
27. MAILLEUX, P. AND VANDERHAEGHEN, J. J.: Distribution of neuronal cannabinoid receptor in the adult brain: A comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48: 655-668, 1992.
28. MEIBACH, R. C. AND SIEGEL, A.: Efferent connections of the septal area in the rat: An analysis utilizing retrograde and anterograde transport methods. Brain Res. 119: 1-20, 1977.
29. MILLER, A. S. AND WALKER, J. M.: Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata. Eur. J. Pharmacol. 279: 179-185, 1995.
30. MUNRO, S., THOMAS, K. L. AND ABU-SHAAR, M.: Molecular characterization of a peripheral receptor for cannabinoids. Nature (Lond.) 365: 61-65, 1993.
31. PACHECO, M., CHILDERS, S. R., ARNOLD, R., CASIANO, F. AND WARD, S. J.: Aminoalkyindoles: Actions on specific G-protein-linked receptors. J. Pharmacol. Exp. Ther. 257: 170-183, 1991.
32. POLK, P.: Electrophysiology of benzodiazepine receptor ligands: Multiple mechanisms and sites of action. Prog. Neurobiol. 31: 349-423, 1988.
33. RINALDI-CARMONA, M., BARTH, F., HÉAULME, M., ALONSO, R., SHIRE, D., CONGY, C., SOUBRIÉ, P., BRELIÉRE, J.-C. AND LE FUR, G.: Biochemical and pharmacological characterization of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 56: 1941-1947, 1995.
34. RINALDI-CÁRMONA, M., BARTH, F., HÉAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NÉLIAT, G., CAPUT, D., FERRARA, P., SOUBRIÉ, P., BRELIÉRE, J.-C. AND LE FUR, G.: SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350: 240-244, 1994.
35. SARTER, M.: Taking stock of cognition enhancers. Trends Phamacol. 12: 456-461, 1991.
36. SMITH, R. B., COMPTON, D. R., WELCH, S. P., RAZDAN, R. K., MECHOULAM, R. AND MARTIN, B. R.: The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp Ther. 270: 219-227, 1994.
37. 9-tetrahydrocannabinol and its relationship to pharmacological potency. J. Pharmacol. Exp. Ther. 225: 624-630, 1990.
38. VOGEL, Z., BARG, J., LEVY, R., SAYA, D., HELDMAN, E. AND MECHOULAM, R.: Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J. Neurochem. 61: 352-355, 1993.
39. WARD, S. J., MASTRIANI, D., CASIANO, F. AND ARNOLD, R.: Pravadoline: Profile in isolated tissue preparations. J. Pharmacol. Exp. Ther. 255: 1230-1239, 1990.
40. WESTPHAL, R. S., BACKSTROM, J. R. AND SANDERS-BUSH, E.: Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. Mol. Pharmacol. 48: 200-205, 1995.
41. XUE, B. G., BELLUZZI, J. D. AND STEIN, L.: In vitro reinforcement of hippocampel bursting by the cannabinoid receptor agonist (-)-CP-55,940. Brain Res. 626: 272-277, 1993.
42. ZOLA-MORGAN, S. AND SQUIRE, L. R.: Neuroanatomy of memory. Annu. Rev. Neurosci. 16: 547-563, 1993.